Order of the Government of the Russian Federation dated December 18, 2025 N 3867-r “On approval of the list of vital and essential medicines, as well as lists of medicines for medical use and the minimum range of medicines necessary for the provision of medical care” Appendix 1.List of vital and essential drugs for medical use for 2026 Appendix 2.List of medications intended to provide persons with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic-uremic syndrome, juvenile arthritis with systemic onset, mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary deficiency of factors II (fibrinogen), VII (labile), X (Stuart-Prower), persons after organ and (or) tissue transplantation Appendix 3.Minimum range of medications required to provide medical care Expired: Order of the Government of the Russian Federation dated October 12, 2019 N 2406-r (as amended on January 15, 2025) Appendix 1.List of vital and essential drugs for medical use for 2025 Appendix 2.List of medications for medical use, including medications for medical use prescribed by decision of medical commissions of medical organizations. - No longer valid Appendix 3.List of medications intended to provide persons with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic-uremic syndrome, juvenile arthritis with systemic onset, mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary deficiency of factors II (fibrinogen), VII (labile), X (Stuart-Prower), persons after organ and (or) tissue transplantation